FirmaIQ
Org.nr 936 656 013 2021 → 2022 Year-over-year analysis

MEDISTIM ASA: årsregnskap 2022 vs 2021

Grew 19% on revenue, stronger earnings, fresh owner capital

approved 2023-04-24; registry 2023-06-14; journal 2023 449437

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2022 with 2021 for MEDISTIM ASA. Revenue 258.5k NOK → 308.6k NOK (+19.4%). Net result +80.68m NOK → +108.11m NOK. Equity 160.3k NOK → 191.7k NOK.

On the constructive side: revenue rose; operating result improved; net result improved.

Also worth watching: cogs moved; book investments changed. All figures are taken from the published annual accounts for MEDISTIM ASA.

At a glance

Scorecard

Revenue
258.5k NOK 308.6k NOK
+19.4%
Operating result
+77.28m NOK +101.69m NOK
+31.6%
Net result
+80.68m NOK +108.11m NOK
+34.0%
Equity
160.3k NOK 191.7k NOK
+19.5%
Cash
75.15m NOK 84.03m NOK
+11.8%
Total assets
310.4k NOK 382.2k NOK
+23.1%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 258.5k NOK to 308.6k NOK (+19.4% YoY). Calculated

  • ↑

    Operating result improved

    Operating result +77.28m NOK → +101.69m NOK (op. margin 29893.5% → 32948.2%). Calculated

  • ↑

    Net result improved

    Net result +80.68m NOK → +108.11m NOK (net margin 31209.0% → 35026.3%). Calculated

  • ↑

    Equity strengthened

    Book equity 160.3k NOK → 191.7k NOK (equity ratio 51.7% → 50.2%). Calculated

  • ↑

    Cash rose

    Bank deposits 75.15m NOK → 84.03m NOK (+11.8% YoY). Calculated

Things to notice

  • ·

    COGS moved

    COGS / varekostnad 54.58m NOK → 63.99m NOK (+17.2% YoY). Calculated

  • ·

    Book investments changed

    Investment / intangible book value 48.38m NOK → 49.37m NOK. Reported fact